Cargando…

Fatal Mucormycosis and Aspergillosis in an Atypical Host: What Do We Know about Mixed Invasive Mold Infections?

Mixed invasive mold infections (MIMIs) are considered rare. We present a case of fatal aspergillosis and mucormycosis in an elderly host with history of chronic lymphocytic leukemia (CLL) and potential mold exposures. Notably, he had no classic risk factors for IMI other than high-dose corticosteroi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsikala-Vafea, Maria, Cao, Weibiao, Olszewski, Adam J., Donahue, John E., Farmakiotis, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471810/ https://www.ncbi.nlm.nih.gov/pubmed/32908735 http://dx.doi.org/10.1155/2020/8812528

Ejemplares similares

191. The impact of antibiotic use on clinical outcomes in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis
por: Vafea, Maria Tsikala, et al.
Publicado: (2020)

COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review
por: Benhadid-Brahmi, Yasmine, et al.
Publicado: (2022)

COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis
por: Huang, Shiang-Fen, et al.
Publicado: (2023)

COVID-19 Prevention in Solid Organ Transplant Recipients: Current State of the Evidence
por: Vafea, Maria Tsikala, et al.
Publicado: (2023)

FRI194 Pheochromocytoma Presenting As Catecholamine-Induced Cardiomyopathy: A Case Report
por: Vafea, Maria Tsikala, et al.
Publicado: (2023)

THU322 Lower HbA1c Is Associated With Lower In-Hospital Mortality In Patients With COVID-19
por: Tsikala Vafea, Maria, et al.
Publicado: (2023)

Disseminated Mucormycosis with Positive Aspergillus Galactomannan
por: Kitmiridou, Despoina, et al.
Publicado: (2018)

Advances against Aspergillosis and Mucormycosis
por: Stevens, David A.
Publicado: (2020)

What Do We Know So Far About Gastrointestinal and Liver Injuries Induced by SARS-CoV-2 Virus?
por: Cao, Weibiao
Publicado: (2020)

Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections
por: Donnelley, Monica A, et al.
Publicado: (2016)

Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia
por: Vučićević Boras, Vanja, et al.
Publicado: (2019)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021)

COVID-19 associated with concomitant mucormycosis and aspergillosis
por: Lai, Chih-Cheng, et al.
Publicado: (2022)

Dexamethasone: Pulmonary aspergillosis and mucormycosis: case report
Publicado: (2021)

Molecular environment and atypical function: What do we know about enzymes associated with Mucopolysaccharidoses?
por: Kong, Weijing, et al.
Publicado: (2022)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

A fatal case report of invasive pulmonary aspergillosis and mucormycosis coinfection in an immunocompetent patient with coronavirus disease 2019 in Korea
por: Kim, Jin Hyoung, et al.
Publicado: (2023)

What We Know and Don't Know About Lyme Disease
por: Donta, Sam T.
Publicado: (2022)

Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
por: Johnson, Andre K., et al.
Publicado: (2021)

Isolated cerebral Mucormycosis and Aspergillosis coinfection in an immunocompromised adult
por: Sun, George, et al.
Publicado: (2023)

The Role of the Microbiome in Autism: All That We Know about All That We Don’t Know
por: David, Maude M.
Publicado: (2021)

All You Need to Know and More about the Diagnosis and Management of Rare Mold Infections
por: Hoenigl, Martin, et al.
Publicado: (2021)

What We Know and Do Not Know about Sex and Cardiac Disease
por: Konhilas, John P.
Publicado: (2010)

What do we know about neutrinos?
por: Vannucci, François
Publicado: (1994)

Bacteria and What We Know about Them
por: Fort, J. M.
Publicado: (1905)

What do we know about pseudodementia?
por: Mouta, Salomé, et al.
Publicado: (2023)

The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
por: Ghosh, Asmita, et al.
Publicado: (2021)

Mucormycosis and Aspergillosis Infection Following Maxillofacial Trauma: Case Report
por: Sardeshmukh, Amruta Anil, et al.
Publicado: (2023)

Breaking the mold: A case of pulmonary mucormycosis treated with isavuconazole
por: Huggins, Jonathan, et al.
Publicado: (2018)

Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient
por: Hu, Zhi-min, et al.
Publicado: (2021)

Diet Modification and Metformin Have a Beneficial Effect in a Fly Model of Obesity and Mucormycosis
por: Shirazi, Fazal, et al.
Publicado: (2014)

What we know and what we need to know about the origin of SARS-CoV-2
por: Domingo, Jose L.
Publicado: (2021)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Transcranial Electrical Stimulation: What We Know and Do Not Know About Mechanisms
por: Fertonani, Anna, et al.
Publicado: (2016)

An overview of reviews: what do we know about task shifting and skill mix change in healthcare?
por: Meda, F, et al.
Publicado: (2023)

What we know about mathematics teaching and learning
por: McREL
Publicado: (2010)

RESCO? Now we know what is it all about!
Publicado: (1980)

What do we know about the Higgs boson ?
por: Gambino, Paulo
Publicado: (2002)

What we still don't know about AIDS
por: Robertson, Miranda
Publicado: (2009)

The disordered mind: what we know about schizophrenia
por: O'Brien, P T
Publicado: (1978)

Cannot write session to /tmp/vufind_sessions/sess_mp7mmsl67l82v48o1113k7qgds